0

BIA 2-093

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP236395145
CAS236395-14-5
Structure
MDL NumberMFCD06798333
Molecular Weight296.32
InChI KeyQIALRBLEEWJACW-INIZCTEOSA-N
Description≥98% (HPLC), solid
SolubilityDMSO: ~21 mg/mL; H2O: insoluble
Assay≥98% (HPLC)
Colorwhite
Formsolid
Size10MG, 50MG
Storage Conditions2-8°C
1

Eslicarbazepine Acetate (BIA 2-093)

Luis Almeida, Patrício Soares-da-Silva

Neurotherapeutics. 2007 Jan;4(1):88-96.

PMID: 17199020

1

Interaction of the Novel Anticonvulsant, BIA 2-093, With Voltage-Gated Sodium Channels: Comparison With Carbamazepine

M J Bonifácio, R D Sheridan, A Parada, R A Cunha, L Patmore, P Soares-da-Silva

Epilepsia. 2001 May;42(5):600-8.

PMID: 11380566

1

Safety, Tolerability and Pharmacokinetic Profile of BIA 2-093, a Novel Putative Antiepileptic Agent, During First Administration to Humans

Luis Almeida, Patrício Soares-da-Silva

Drugs R D. 2003;4(5):269-84.

PMID: 12952496

1

Safety, Tolerability, and Pharmacokinetic Profile of BIA 2-093, a Novel Putative Antiepileptic, in a Rising Multiple-Dose Study in Young Healthy Humans

Luis Almeida, Patrício Soares-da-Silva

J Clin Pharmacol. 2004 Aug;44(8):906-18.

PMID: 15286095

1

The Novel Anticonvulsant BIA 2-093 Inhibits Transmitter Release During Opening of Voltage-Gated Sodium Channels: A Comparison With Carbamazepine and Oxcarbazepine

António Parada, Patríjcio Soares-da-Silva

Neurochem Int. 2002 Apr;40(5):435-40.

PMID: 11821151

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode